These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
660 related articles for article (PubMed ID: 8759659)
1. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. Santander C; Grávalos RG; Gómez-Cedenilla A; Cantero J; Pajares JM Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659 [TBL] [Abstract][Full Text] [Related]
2. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN; Hahm JS; Kim HJ Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924 [TBL] [Abstract][Full Text] [Related]
4. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy. Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464 [TBL] [Abstract][Full Text] [Related]
5. The effect of antibiotic therapy on bleeding from duodenal ulcer. Sonnenberg A; Olson CA; Zhang J Am J Gastroenterol; 1999 Apr; 94(4):950-4. PubMed ID: 10201462 [TBL] [Abstract][Full Text] [Related]
6. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients. Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519 [TBL] [Abstract][Full Text] [Related]
7. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study. Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317 [TBL] [Abstract][Full Text] [Related]
8. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication. Avidan B; Melzer E; Keller N; Bar-Meir S Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370 [TBL] [Abstract][Full Text] [Related]
9. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic]. Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978 [TBL] [Abstract][Full Text] [Related]
10. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200 [TBL] [Abstract][Full Text] [Related]
11. A 3-day anti-Helicobacter pylori therapy is a good alternative for bleeding peptic ulcer patients with Helicobacter pylori infection. Hsieh YH; Lin HJ; Tseng GY; Perng CL; Chang FY; Lee SD Hepatogastroenterology; 2001; 48(40):1078-81. PubMed ID: 11490804 [TBL] [Abstract][Full Text] [Related]
12. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence]. Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208 [TBL] [Abstract][Full Text] [Related]
13. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer]. Kayser S; Flury R; Zbinden R; Fried M; Wirth HP Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483 [TBL] [Abstract][Full Text] [Related]
14. The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer. Horvat D; Vcev A; Soldo I; Timarac J; Dmitrović B; Misević T; Ivezić Z; Kraljik N Coll Antropol; 2005 Jun; 29(1):139-42. PubMed ID: 16117312 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of quadruple therapy in the eradication of Helicobacter pylori and prevention of recurrent duodenal ulcer]. Ocaña Andrade E; Espinosa Soberanes JA; Mares Zambrano MA; Rosete Reyes A Rev Gastroenterol Mex; 1998; 63(4):182-6. PubMed ID: 10319667 [TBL] [Abstract][Full Text] [Related]
16. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study. Macri G; Milani S; Surrenti E; Passaleva MT; Salvadori G; Surrenti C Am J Gastroenterol; 1998 Jun; 93(6):925-7. PubMed ID: 9647020 [TBL] [Abstract][Full Text] [Related]
17. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients. Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716 [TBL] [Abstract][Full Text] [Related]
18. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. Sung JJ; Chung SC; Ling TK; Yung MY; Leung VK; Ng EK; Li MK; Cheng AF; Li AK N Engl J Med; 1995 Jan; 332(3):139-42. PubMed ID: 7800005 [TBL] [Abstract][Full Text] [Related]
19. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452 [TBL] [Abstract][Full Text] [Related]
20. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S; J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]